Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;108(2):127-34.
doi: 10.1093/qjmed/hcu170. Epub 2014 Aug 19.

End-stage renal disease and survival in people with diabetes: a national database linkage study

Affiliations

End-stage renal disease and survival in people with diabetes: a national database linkage study

S Bell et al. QJM. 2015 Feb.

Abstract

Background: Increasing prevalence of diabetes worldwide is projected to lead to an increase in patients with end-stage renal disease (ESRD) requiring renal replacement therapy (RRT).

Aim: To provide contemporary estimates of the prevalence of ESRD and requirement for RRT among people with diabetes in a nationwide study and to report associated survival.

Methods: Data were extracted and linked from three national databases: Scottish Renal Registry, Scottish Care Initiative-Diabetes Collaboration and National Records of Scotland death data. Survival analyses were modelled with Cox regression.

Results: Point prevalence of chronic kidney disease (CKD)5 in 2008 was 1.63% of 19 414 people with type 1 diabetes (T1DM) compared with 0.58% of 167 871 people with type 2 diabetes (T2DM) (odds ratio for DM type 0.97, P = 0.77, on adjustment for duration. Although 83% of those with T1DM and CKD5 and 61% of those with T2DM and CKD5 were receiving RRT, there was no difference when adjusted for age, sex and DM duration (odds ratio for DM type 0.83, P = 0.432). Diabetic nephropathy was the primary renal diagnosis in 91% of people with T1DM and 58% of people with T2DM on RRT. Median survival time from initiation of RRT was 3.84 years (95% CI 2.77, 4.62) in T1DM and 2.16 years (95% CI: 1.92, 2.38) in T2DM.

Conclusion: Considerable numbers of patients with diabetes continue to progress to CKD5 and RRT. Almost half of all RRT cases in T2DM are considered to be due to conditions other than diabetic nephropathy. Median survival time for people with diabetes from initiation of RRT remains poor. These prevalence data are important for future resource planning.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Identification of records included in study.
Figure 2.
Figure 2.
Primary causes of renal disease in those with T1DM and T2DM receiving RRT. Among those with T2DM, multisystem diseases comprise of the following: Renal vascular disease—type unspecified (32%); renal vascular disease due to hypertension (no primary renal disease) (23%); myelomatosis/light chain deposit disease (11%); and renal vascular disease due to other cause (11%).

References

    1. International Diabetes Federation. IDF Diabetes Atlas. 6th edn. Brussels, Belgium: International Diabetes Federation; 2013. . http://www.idf.org/diabetesatlas (18 April 2014, date last accessed) - PubMed
    1. Scottish Diabetes Survey Monitoring Group. Scottish Diabetes Survey 2003. Scotland: NHS National Services; www.scotland.gov.uk/Publications/2004/10/20023/44194 (19 April 2014, date last accessed)
    1. Scottish Diabetes Survey Monitoring Group. Scottish Diabetes Survey 2012. Scotland: NHS National Services; www.diabetesinscotland.org/Publications/SDS%202012.pdf(19 April 2014, date last accessed)
    1. Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000) Kidney Int. 2005;67:1489–99. - PubMed
    1. Information Services Division NHS National Services Scotland. Scottish Renal Registry report 2011. NHS National Services Scotland 2012.

Publication types